[Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
出版信息
Fortschr Med. 1982 Nov 25;100(44):2059-60.
PMID:7173786
Abstract
摘要
相似文献
1
[Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
Fortschr Med. 1982 Nov 25;100(44):2059-60.
2
[Treatment with lactulose. A low-risk alternative in various diseases].
Fortschr Med. 1984 Dec 6;102(45):1167-70.
3
[Lactulose].
Gastroenterol Clin Biol. 1990;14(6-7):567-75.
4
Medical, nutritional and technological properties of lactulose. An update.乳果糖的医学、营养及技术特性。最新进展。
Eur J Nutr. 2002 Nov;41 Suppl 1:I17-25. doi: 10.1007/s00394-002-1103-6.
5
[Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
Orv Hetil. 1993 Jun 27;134(26):1417-9.
6
Lactulose for hepatic encephalopathy.
Med Lett Drugs Ther. 1976 Jan 2;18(1):3-4.
7
[Treatment of hepatic encephalopathy with lactulose].
Med Arh. 1981;35(5-6):267-9.
8
The use of lactulose in portal-systemic encephalopathy.
Conn Med. 1978 Feb;42(2):96-7.
9
Portal systemic encephalopathy--should lactulose and neomycin be used together.
Br J Clin Pract. 1981 Sep;35(9):323-4.
10
[Lactulose in the treatment of hepatic (pre)coma].
Ned Tijdschr Geneeskd. 1978 Feb 11;122(6):198-200.
Zotero 插件